Trader consensus reflected in the 96.5% market-implied probability for no new pandemic in 2026 stems primarily from the absence of any novel pathogen achieving sustained global human-to-human transmission through late October. Official WHO and ECDC surveillance shows low global influenza, SARS-CoV-2, and RSV activity, while the large Bundibugyo Ebola outbreak in the Democratic Republic of the Congo—now exceeding 10,000 confirmed cases with limited spread to Kenya and Nigeria—remains regionally contained due to its transmission characteristics and ongoing contact tracing. Historical patterns indicate Ebola rarely escalates to pandemic scale, and no new zoonotic or respiratory threats have met WHO pandemic criteria. Realistic scenarios that could still alter the outcome before year-end include undetected emergence of an efficiently transmissible novel strain or significant changes in surveillance data.